Clinical Trial Update: Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

A preliminary Phase 1 study is planned to evaluate UTAA09 injections for relapsed/refractory autoimmune diseases, with recruitment not yet started. The conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Idiopathic Inflammatory Myopathies
• Immune Thrombocytopenia
• Rheumatoid Arthritis
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• UTAA09

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies | EARLY_Phase 1 | Status: NOT_YET_RECRUITING